Chronic Kidney Disease (CKD) Drugs Market Globally Grow at a CAGR of 1.21% by Revenue During the Forecast Period 2016-2019
ResearchMoz presents this most up-to-date research on Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019. About CKD According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public health issue. CKD is classified into five stages (stages 1-5) according to renal function and the level of urinary protein excretion as measured by eGFR which is derived from race, gender, age, and serum creatinine concentration. TechNavio's analysts forecast the Global CKD Drugs market to grow at a CAGR of 1.21 percent over the period 2014-2019. Covered: The Global CKD Drugs Market can be divided into two segments: Route of Administration which includes oral, SC, a...